PMID- 32715366 OWN - NLM STAT- MEDLINE DCOM- 20210618 LR - 20210618 IS - 1573-2630 (Electronic) IS - 0165-5701 (Linking) VI - 40 IP - 12 DP - 2020 Dec TI - Blood thiamine pyrophosphate concentration and its correlation with the stage of diabetic retinopathy. PG - 3279-3284 LID - 10.1007/s10792-020-01513-2 [doi] AB - PURPOSE: To assess the possible relationship between blood thiamine pyrophosphate (TPP) concentration and stage of diabetic retinopathy (DR). METHODS: This comparative cross-sectional study included 80 patients with type 2 diabetes mellitus (T2DM) and 20 age- and gender-matched healthy controls. Diabetic patients were subclassified into four groups each consisting of 20 subjects: no DR, mild-moderate non-proliferative DR (mild-moderate NPDR), severe NPDR, and proliferative DR (PDR). Blood TPP concentration was assessed with high-performance liquid chromatography (HPLC) assay and was correlated with the stage of DR. RESULTS: Mean blood TPP concentration was 80.2 +/- 14.8 nmol/L in control group. It was, respectively, 69.85 +/- 18.1, 64.95 +/- 13.4, 61.9 +/- 13.4 and 60.75 +/- 14.3 nmol/L in no DR, mild-moderate NPDR, severe NPDR and PDR groups. For mild-moderate NPDR, severe NPDR and PDR groups, TPP concentrations were significantly lower compared with controls (p: 0.014, 0.002, 0.001, respectively). Mean TPP concentration for NPDR patients was higher than for PDR patients, but the difference was not significant (p: 0.478). ANOVA revealed a significant difference between TPP concentrations of groups (p: 0.001). Mean TPP concentration decreased with the stage of DR, and number of patients with thiamine deficiency increased gradually with the stage of DR. A negative correlation was found between the TPP level and occurrence of DR (p: 0.000). CONCLUSION: The results suggest that lower blood TPP concentrations were associated with higher risk of DR. Thiamine might play an important role in the pathophysiology and progression of DR. Thiamine and its derivatives might represent an approach to the prevention and/or treatment of early DR. FAU - Cinici, Emine AU - Cinici E AD - Department of Ophthalmology, Faculty of Medicine, Ataturk University, Erzurum, Turkey. FAU - Dilekmen, Nilay AU - Dilekmen N AUID- ORCID: 0000-0003-2131-0975 AD - Department of Ophthalmology, Palandoken State Hospital, 25100, Erzurum, Turkey. nilaydilekmen@yahoo.com. FAU - Senol, Onur AU - Senol O AD - Department of Analytical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey. FAU - Arpali, Eren AU - Arpali E AD - Department of Ophthalmology, Regional Training and Research Hospital, Erzurum, Turkey. FAU - Cinici, Ozkan AU - Cinici O AD - Department of Internal Medicine, Regional Training and Research Hospital, Erzurum, Turkey. FAU - Tanas, Serdar AU - Tanas S AD - Department of Internal Medicine, Taksim Regional Training and Research Hospital, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20200726 PL - Netherlands TA - Int Ophthalmol JT - International ophthalmology JID - 7904294 RN - Q57971654Y (Thiamine Pyrophosphate) SB - IM MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/complications MH - *Diabetic Retinopathy/diagnosis MH - Humans MH - Thiamine Pyrophosphate OTO - NOTNLM OT - Blood thiamine pyrophosphate concentration OT - Diabetic retinopathy OT - Thiamine OT - Thiamine pyrophosphate EDAT- 2020/07/28 06:00 MHDA- 2021/06/22 06:00 CRDT- 2020/07/28 06:00 PHST- 2020/05/14 00:00 [received] PHST- 2020/07/17 00:00 [accepted] PHST- 2020/07/28 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/07/28 06:00 [entrez] AID - 10.1007/s10792-020-01513-2 [pii] AID - 10.1007/s10792-020-01513-2 [doi] PST - ppublish SO - Int Ophthalmol. 2020 Dec;40(12):3279-3284. doi: 10.1007/s10792-020-01513-2. Epub 2020 Jul 26.